pain conditions
Pop star calls for awareness on endometriosis delay
Singer Ella Henderson says it took years of symptoms and repeated GP visits before she was finally diagnosed with endometriosis earlier this year.
The 29-year-old former X Factor contestant was diagnosed in January after undergoing a laparoscopy – a form of keyhole surgery – which revealed severe endometriosis behind her uterus, along with scar tissue affecting her bladder and bowel.
Her story echoes a wider issue in women’s health.
It takes an average of up to nine years to diagnose endometriosis in the UK.
The condition affects about one in 10 women aged 15 to 49 and occurs when tissue similar to the lining of the womb develops in different areas of the body.
Henderson said in a statement on Instagram: “After years of struggling with confusing and challenging health problems including stomach bloating, bowel pain and heavy periods, plus countless GP appointments leading to scans, tests and the feeling that maybe the pain was all in my head, I was officially diagnosed with endometriosis in January this year.
“My long journey to an endometriosis diagnosis is not unique. It takes on average up to nine years in the UK, which for many like me, can put an immense mental and physical toll on you.”
Symptoms can include intense pain and substantial bleeding, which are often mistaken for other conditions such as irritable bowel syndrome or pelvic inflammatory disease.
She said: “Living in chronic pain, not being believed, and constant misdiagnosis led to periods of depression, isolation and anxiety.
“If health practitioners had recognised my endometriosis symptoms sooner, I might have been spared all that.”
Henderson underwent surgery which she said had “significantly” improved her symptoms.
While there is no cure for endometriosis, treatments are available to help manage the pain.
She has since partnered with Endometriosis UK, a charity focused on raising awareness of the condition.
Henderson said: “I don’t want future generations of women to go through what I did.
“I know that my situation isn’t unique, and too many women unnecessarily suffer with undiagnosed endometriosis for far too long.
“My hope is to be a voice for those still searching for answers and show those living with endometriosis that they’re not alone.
“I want anyone living with this condition to feel a sense of empowerment and be enabled to take back control of their lives by knowing what is actually going on with their bodies.”
A non-profit has launched an endometriosis documentary featuring Amy Schumer and Marilyn Monroe as it pushes for changes in how the condition is treated and understood.
The Endometriosis Collective has launched to change how endometriosis is researched, treated and understood, starting with a documentary featuring stories from people including Amy Schumer and Marilyn Monroe.
The feature-length documentary, “End of the Cycle”, will premiere in New York on Tuesday, and The Endometriosis Collective is making the film free to stream online.
Schumer, a comedian, writer and actor, has previously spoken of how endometriosis left her “on the floor in pain, vomiting from the pain, the pain that nobody can see.”
Schumer is one of several celebrities featured in the documentary. Other contributors include dancer Julianne Hough, Olympic medallist Brittany Brown and actors Janel Parrish and Folake Olowofoyeku.
The Endometriosis Collective timed the documentary premiere to coincide with the 100th anniversary of Marilyn Monroe’s birth.
Monroe, who died in 1962, starred in films such as “Some Like It Hot” and “Gentlemen Prefer Blondes.”
According to a biography published in 1985, Monroe’s endometriosis was so severe that it destroyed her marriages, her wish for children, her career and ultimately her life.
The Endometriosis Collective said the documentary shares newly uncovered information about Monroe’s experience with endometriosis.
The non-profit said the information connects Monroe’s story to the experiences of women across generations, highlighting how far awareness, research and care still have to go.
A representative of the Marilyn Monroe Estate said: “By sharing this part of her story through ‘End of the Cycle,’ we hope to honour her legacy in a way that brings visibility to endometriosis, encourages more open dialogue and helps inspire the research needed to create change.”
As part of the premiere, The Endometriosis Collective is holding a panel discussion.
Schumer, Brown and Olowofoyeku, the documentary’s co-directors Sammy Jaye and Soraya Simi, and medical experts are due to be part of the premiere.
AbbVie’s Orilissa and Sumitomo Pharma’s Myfembree are among the approved drugs for endometriosis pain.
Hough, one of the participants in the documentary, starred in an Orilissa campaign in 2017.
Supermarket loyalty card data suggests more than a quarter of women buying menstrual products also buy pain relief at the same time.
The findings also suggest women in lower-income areas are significantly less likely to do so, pointing to disparities in access to over-the-counter pain relief across England.
The study was led by Dr Victoria Sivill of the University of Bristol and colleagues.
The authors said: “The study highlights the need for greater awareness and policy interventions to address the high prevalence of menstrual pain as well as socioeconomic dimensions of menstrual pain.
“Public health initiatives should incorporate menstrual pain relief as part of broader efforts to improve health equity.”
Researchers analysed anonymised loyalty card data from a major UK health and beauty retailer, covering 211m transactions by 3.4m people between 2006 and 2015.
The study examined how often shoppers bought menstrual products and pain relief in the same transaction, and compared this with a customer’s usual rate of buying pain relief.
It found that 26.7 per cent of customers who bought menstrual products also bought pain relief at the same time.
These customers were nearly four times more likely to buy pain relief when buying menstrual products than on other shopping trips.
As a check on the approach, researchers found the most common interval between consecutive menstrual product purchases was exactly 28 days, consistent with the average menstrual cycle.
Menstrual pain is common and can affect daily activities, including school and work attendance.
Regional income was the strongest predictor of menstrual pain purchases.
Customers in the lowest-income areas were 32 per cent less likely to buy pain relief at the same time as menstrual products than those in the highest-income areas.
The authors said lower rates of pain relief purchases in deprived areas are likely to reflect an inability to afford over-the-counter medication rather than lower rates of menstrual pain itself.
Co-author Dr James Goulding said: “It is wonderful that smart data research in the UK is able to bring issues which may have once been overlooked in scientific settings, such as the sheer scale and impact of menstrual pain, to light. This is well overdue.
Co-author Dr Anya Skatova said: “Like many women, I was aware of how common menstrual pain is, but the scale of painkiller purchases alongside menstrual products was still striking.
“Using shopping data, we can see just how widespread the need for pain relief really is. This kind of evidence helps make menstrual pain visible at a population level and provides a strong foundation for systemic change in how it is recognised, treated, and prioritised in public health.”
A major genetics study has found dozens of new signals linked to endometriosis, offering fresh insight into the biology driving the condition.
Endometriosis is a systemic disease affecting around 10 per cent of females worldwide.
It happens when tissue similar to the lining of the uterus grows outside it, causing pain, inflammation and fertility problems.
Despite how common it is, the underlying causes have remained poorly understood, slowing progress in diagnosis and treatment.
In one of the largest investigations to date, researchers analysed genetic data from approximately 1.4 million females, including more than 105,000 with endometriosis.
The study identified 80 genomic regions linked to disease risk, including 37 previously unreported loci, or specific positions on chromosomes, significantly advancing understanding of endometriosis genetics.
Notably, five of these regions were also linked to adenomyosis, a related condition in which endometrial-like tissue grows within the wall of the uterus.
Beyond identifying genetic variants, the researchers integrated transcriptomic, epigenetic and proteomic data, which examine gene activity, chemical changes regulating genes and proteins, to better understand how these variants influence disease development.
This multi-omics approach linked endometriosis genetics to key biological processes, including cell differentiation, immune response, hormonal regulation, tissue remodelling and inflammation.
These findings support long-standing hypotheses that endometriosis is not solely a localised gynaecological condition but a complex, systemic disorder involving immune and hormonal dysregulation.
The study also found that genetic risk for endometriosis interacted with a range of clinical symptoms, including abdominal pain, anxiety, migraine and nausea.
This reinforces the multifaceted nature of the disease and may help explain why patients often experience a broad spectrum of symptoms beyond pelvic pain.
Such insights could improve patient stratification in the future, enabling more personalised approaches to management based on genetic risk profiles.
The analysis also identified potential therapeutic targets through drug-repurposing approaches.
Some of the implicated pathways overlap with those targeted by existing treatments for breast cancer, contraception and preterm birth prevention, raising the possibility of accelerating new treatment strategies for endometriosis.
Menopause3 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health4 weeks agoNHS urged to update website following renaming of PCOS
News2 weeks agoWomen still being failed when they reach menopause, experts say
Entrepreneur3 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Insight2 weeks agoBritish women among angriest in Europe, health survey reveals
News3 weeks agoThree menopause innovators shortlisted for Femtech World Award
Menopause3 weeks agoSweden eyes domestic production of oestrogen patches amid menopause treatment shortage
Menopause4 weeks agoLow insulin diet and avoiding four food groups may prevent menopause weight gain